European Journal of Cancer
Volume 46, Issue 1 , Pages 84-94 , January 2010

Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) – The German Adjuvant Breast Cancer Group

  • Wolfgang Eiermann

      Affiliations

    • Frauenklinik vom Roten Kreuz, Taxistraße 3, 80637 München, Germany
    • Corresponding Author InformationCorresponding author: Tel.: +49 89 15706 620x621; fax: +49 89 15706 623.
    • ,
  • Erika Graf

      Affiliations

    • Medizinische Biometrie und Statistik, Universitätsklinikum Freiburg, Stefan-Meier-Straße 26, 79104 Freiburg, Germany
    • ,
  • Beyhan Ataseven

      Affiliations

    • Frauenklinik vom Roten Kreuz, Taxistraße 3, 80637 München, Germany
    • ,
  • Bettina Conrad

      Affiliations

    • Brustzentrum, Elisabeth-Krankenhaus Kassel, Weinbergstraße 7, 34117 Kassel, Germany
    • ,
  • Jörn Hilfrich

      Affiliations

    • Henriettenstiftung, Schwemannstraße 17, 30559 Hannover, Germany
    • ,
  • Heidi Massinger-Biebl

      Affiliations

    • Gemeinschaftspraxis, Marktplatz/Weißbräugasse 2a, 94065 Waldkirchen, Germany
    • ,
  • Sabine Vescia

      Affiliations

    • Stadtkrankenhaus Hanau, Leimenstr. 20, 63450 Hanau, Germany
    • ,
  • Sibylle Loibl

      Affiliations

    • German Breast Group, GBG Forschungs GmbH, Schleussnerstraße 42, 63263 Neu-Isenburg, Germany
    • ,
  • Gunter von Minckwitz

      Affiliations

    • German Breast Group, GBG Forschungs GmbH, Schleussnerstraße 42, 63263 Neu-Isenburg, Germany
    • Klinik für Gynäkologie und Geburtshilfe, J.W. Goethe Universität, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany
    • ,
  • Martin Schumacher

      Affiliations

    • Medizinische Biometrie und Statistik, Universitätsklinikum Freiburg, Stefan-Meier-Straße 26, 79104 Freiburg, Germany
    • ,
  • Manfred Kaufmann

      Affiliations

    • Klinik für Gynäkologie und Geburtshilfe, J.W. Goethe Universität, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany
    • ,
  • for the German Adjuvant Breast Cancer Group

Received 23 June 2009 ,Revised 1 September 2009 ,Accepted 1 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This report presents the final analysis of trial GABG-IV E-93. Preliminary results were reported at the ASCO Annual Meeting in 2001.

PII: S0959-8049(09)00726-6

doi: 10.1016/j.ejca.2009.10.001

European Journal of Cancer
Volume 46, Issue 1 , Pages 84-94 , January 2010

Article Tools

* Image Usage & Resolution